Glaxon Plasm Surge
Plasm Surge is a Non-Stimulant Pump Pre-Workout designed to stave off fatigue, increase blood flow, vasodilation, and pumps. Whether you're looking for pumps, a non-stimulant pre-workout, or increased vascularity, you can't go wrong with Plasm Surge from Glaxon.
Glaxon Plasm Surge Product Highlights
- Non-Stimulant Pre-Workout
- Increased Pumps & Vascularity
- Stacks Great w/ Glaxon Specimen Pre-Workout
- Increased Blood Flow, Pumps, and Nutrient Absorption
- Great for Late Night Workouts, Won't Keep You Awake
- 3,000mg L-Citrulline
- 750mg Glycerol
What Can I Expect from Plasm Surge?
- Increased Blood Flow
- Incredible Pumps
- Improved Nutrient Absorption
Who Can Take Plasm Surge?
Both men and women looking for a non-stim pre-workout that still provides enhanced performance while training.
What Does Plasm Surge Do?
Plasm Surge is a non-stim pre-workout which increases energy, endurance, and pumps.
Plasm Surge pre workout is best taken 45-60 minutes prior to exercise. You can either take ½ scoop or 1 full scoop dissolved into 16oz (500mL) of water, and mix vigorously!
Glaxon Plasm Surge Supplement Facts
Serving Size: 1/2 Scoop (7500mgs)
Servings Per Container: 42
Magnesium (as Magnesium Gluconate) 15mg
Potassium as (Potassium Gluconate) 34mg
Sodium (as Sodium Citrate) 10mg
Glycerol (as GlycerPump) (65% Glycerol) 750mg
Agmatine Sulfate 500mg
Low Molecular Weight BioActive Peptides (as VasoDrive-AP 50mg
Other Ingredients: Citric Acid, Maltodextrin, Natural & Artificial Flavors, Sucralose, Acesulfame Potassium, HuberSorb
Do not use if you are pregnant or nursing. Do not use if you have any serious medical condition. Store in a cool dry place.
Allerton TD, Proctor DN, Stephens JM, Dugas TR, Spielmann G, Irving BA. l-Citrulline Supplementation: Impact on Cardiometabolic Health. Nutrients. 2018;10(7):921. Published 2018 Jul 19. doi:10.3390/nu10070921
Šalamon Š, Kramar B, Marolt TP, Poljšak B, Milisav I. Medical and Dietary Uses of N-Acetylcysteine. Antioxidants (Basel). 2019;8(5):111. Published 2019 Apr 28. doi:10.3390/antiox8050111